• Level of thyroid-stimulating hormone as basic diagnostic marker and criterion of treatment success of thyroid diseases

Level of thyroid-stimulating hormone as basic diagnostic marker and criterion of treatment success of thyroid diseases

HEALTH OF WOMAN. 2017.4(120):102–106; doi 10.15574/HW.2017.120.102

Pankiv V. I.
Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine organs and tissues of the Ministry of Health of Ukraine, Kyiv

In the article information is generalized on the aspects of early diagnostics of thyrois disorders. The value of thyroid-stimulating hormone is underlined as basic test for determination of the thyroid functional state and criterion of treatment success of thyroid diseases.

Key words: thyroid, thyroid-stimulating hormone, diagnostics.

REFERENCES

1. Kupnovytska IH, Mishchuk VH, Hubina IP ta in. 2016. Patohenetychne znachennia yodu ta tyreoidnykh hormoniv u rozvytku arterialnoi hipertenzii. Visnyk naukovykh doslidzhen 2(31):31–33. doi: 10.11603/2415-8798.2016.2.6691

2. Pankiv VI, Yuzvenko TIu. 2016. Vzaiemozv’iazok subklinichnoi dysfunktsii shchytopodibnoi zalozy i metabolichnoho syndromu. Klinichna endokrynolohiia ta endokrynna khirurhiia 3:54–59.

3. Pashkovska NV. 2016. Likuvannia hipotyreozu zghidno iz suchasnymy klinichnymy nastanovamy. Mizhnarodnyi endokrynolohichnyi zhurnal 6(78):48-58 doi: 10.22141/2224-0721.6.78.2016.81860

4. Bahn RS, Burch HB, Cooper DS et al. 2011. American Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 21(6):593-646. https://doi.org/10.1089/thy.2010.0417.

5. Clinical Management of Thyroid Disease. Ed. by FE Wondisford, S Radovick. – Baltimore, Maryland; John Hopkins University School of Medicine. 2009:860.

6. Kahapola-Arachchige KM, Hadlow N, Wardrop R et al. 2012, Nov. Age-specific TSH reference ranges have minimal impact on the diagnosis of thyroid dysfunction. Clin Endocrinol (Oxf). 77(5):773-9. https://doi.org/10.1111/j.1365-2265.2012.04463.x.

7. Koulouri O, Auldin MA, Agarwal R et al. 2011. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine. Clin Endocrinol (Oxf). 74(6):744-749. https://doi.org/10.1111/j.1365-2265.2011.03984.x.

8. Menconi F, Marcocci C, Marinò M. 2014. Diagnosis and classification of Graves’ disease. Autoimmun Rev. 13(4–5):398–402. doi: 10.1016/j.autrev.2014.01.013. https://doi.org/10.1016/j.autrev.2014.01.013